Venetoclax Plus Intensive Chemotherapy
Phase 1B Study of Venetoclax in Combination With Standard Intensive Chemotherapy With Daunorubicin Plus Cytarabine Followed by High-Dose Cytarabine in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia and Advanced Myelodysplastic Syndrome
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 99 patients (estimated)
- Sponsors
- Montefiore Medical Center
- Tags
- BCL-2 Inhibitor, Chemotherapy
- Trial Type
- Treatment
- Last Update
- 4 weeks ago
- SparkCures ID
- 1515
- NCT Identifier
- NCT05342584
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.